Geode Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Geode Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-669,035	Closed	-$25.2M	–	4776
2021 Q1	$25.2M	Buy	669,035 +39,343	+6%	+$1.48M	﹤0.01%	1727
2020 Q4	$10.7M	Buy	629,692 +90,236	+17%	+$1.53M	﹤0.01%	2127
2020 Q3	$2.54M	Buy	539,456 +43,196	+9%	+$203K	﹤0.01%	2753
2020 Q2	$3.03M	Sell	496,260 -42,529	-8%	-$259K	﹤0.01%	2605
2020 Q1	$1.22M	Buy	538,789 +22,965	+4%	+$52.1K	﹤0.01%	2927
2019 Q4	$2.37M	Buy	515,824 +50,227	+11%	+$230K	﹤0.01%	2913
2019 Q3	$1.8M	Buy	465,597 +15,183	+3%	+$58.8K	﹤0.01%	2998
2019 Q2	$2.72M	Buy	450,414 +22,025	+5%	+$133K	﹤0.01%	2752
2019 Q1	$5.74M	Buy	428,389 +18,688	+5%	+$250K	﹤0.01%	2251
2018 Q4	$3.81M	Buy	409,701 +38,601	+10%	+$359K	﹤0.01%	2387
2018 Q3	$5.17M	Buy	371,100 +6,444	+2%	+$89.7K	﹤0.01%	2337
2018 Q2	$5.76M	Buy	364,656 +35,309	+11%	+$558K	﹤0.01%	2247
2018 Q1	$5.66M	Buy	329,347 +67,820	+26%	+$1.16M	﹤0.01%	2164
2017 Q4	$5.73M	Buy	261,527 +1,792	+0.7%	+$39.3K	﹤0.01%	2133
2017 Q3	$10.6M	Buy	259,735 +17,547	+7%	+$718K	﹤0.01%	1680
2017 Q2	$7.29M	Buy	242,188 +2,553	+1%	+$76.9K	﹤0.01%	1875
2017 Q1	$8.66M	Sell	239,635 -10,792	-4%	-$390K	﹤0.01%	1715
2016 Q4	$12.5M	Buy	250,427 +7,161	+3%	+$359K	0.01%	1437
2016 Q3	$12.8M	Buy	243,266 +21,297	+10%	+$1.12M	0.01%	1327
2016 Q2	$9.18M	Buy	221,969 +33,751	+18%	+$1.4M	0.01%	1498
2016 Q1	$7.65K	Buy	188,218 +4,679	+3%	+$190	﹤0.01%	1575
2015 Q4	$7.62M	Buy	183,539 +46,213	+34%	+$1.92M	﹤0.01%	1571
2015 Q3	$2.11M	Buy	137,326 +7,839	+6%	+$121K	﹤0.01%	2404
2015 Q2	$3.22M	Sell	129,487 -11,754	-8%	-$292K	﹤0.01%	2202
2015 Q1	$3.23M	Buy	141,241 +69,864	+98%	+$1.6M	﹤0.01%	2126
2014 Q4	$1.93M	Buy	71,377 +18,114	+34%	+$489K	﹤0.01%	2460
2014 Q3	$624K	Sell	53,263 -7	-0%	-$82	﹤0.01%	3057
2014 Q2	$828K	Buy	53,270 +7,799	+17%	+$121K	﹤0.01%	2903
2014 Q1	$893K	Buy	45,471 +15,899	+54%	+$312K	﹤0.01%	2856
2013 Q4	$496K	Buy	+29,572	New	+$496K	﹤0.01%	3094